
About LepiDyne
LepiDyne is a Healthcare company based in Seoul (South Korea) founded in 2019. Developer of liquid biopsy test kits for cancer detection. Its chief executive, as recorded, is Young Joon Kim. LepiDyne offers products and services including MethyLiverDx, MethyLiverPro, MethyLiverMT, and LepiMag. Its focus areas include Life Sciences, Oncology, In-Vitro Diagnostic Tests and Diversified. Its legal entity in India is (μ£Ό)λ νΌλ€μΈ (U99999MH1977PLC010754).
Company details
LepiDyne was founded in 2019 in Seoul, South Korea, where tumor-specific DNA methylation markers in blood are discovered, developed, and clinically validated for cancer detection. Operations center on liquid biopsy technologies within the biotechnology sector. Key products, including MethyLiverDx, MethyLiverPro, and MethyLiverMT, are offered for liver cancer diagnostics. Leadership is provided by CEO Young Joon Kim, with activities based in South Korea.
- Headquarters Seoul, South Korea
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website lepidyne.com
- Legal Name (주)레피다인
- Date of Incorporation 10 Aug, 1977
- Jurisdiction Maharashtra, India
Associated legal entities of LepiDyne
LepiDyne operates through , (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| , CIN U99999MH1977PLC010754 | Active | 10 Aug 1977 | Nanded, Maharashtra | View details |
Products & Services of LepiDyne
LepiDyne offers a comprehensive portfolio of products and services, including MethyLiverDx, MethyLiverPro, MethyLiverMT, and LepiMag.
Kit for early blood-based diagnosis of liver cancer
Kit for predicting liver cancer treatment outcomes
Kit for monitoring liver cancer treatment progress
Kit for extracting cell-free DNA from blood samples
People of LepiDyne
1 people are tracked at LepiDyne (1 in leadership).
| Name | Role | Group |
|---|---|---|
Young Joon Kim | CEO | Leadership |
Complete people profiles for LepiDyne
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Web traffic of LepiDyne
The website of LepiDyne (lepidyne.com) receives about 1.8K visits a month.
- Monthly visits1.8K
▲ 135.2% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Lepidyne
Complete news archive for LepiDyne
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about LepiDyne
LepiDyne was founded in 2019.
LepiDyne is headquartered in Seoul, South Korea.
Young Joon Kim is the CEO of LepiDyne, as recorded in our data.
LepiDyne was founded in 2019 in Seoul, South Korea, where tumor-specific DNA methylation markers in blood are discovered, developed, and clinically validated for cancer detection. Operations center on liquid biopsy technologies within the biotechnology sector. Key products, including MethyLiverDx, MethyLiverPro, and MethyLiverMT, are offered for liver cancer diagnostics. Leadership is provided by CEO Young Joon Kim, with activities based in South Korea.
LepiDyne offers MethyLiverDx, MethyLiverPro, MethyLiverMT, and LepiMag.
LepiDyne operates through ,.
